Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Primary Objective: To investigate effects of SAR440340 (anti-interleukin-33 [IL?33] monoclonal antibody [mAb]) compared with placebo, on the annualized rate of moderate-to-severe acute exacerbations of COPD (AECOPD) over up to 52 weeks of treatment.
Read More
Use of the STTGMA Tool to Risk Stratify 1-Year Functional Outcomes and Mortality in Geriatric Trauma Patients
Konda, S. R., Lott, A., Saleh, H., Gales, J., & Egol, K. A. (2018). Use of the STTGMA Tool to Risk Stratify 1-Year Functional Outcomes and Mortality in Geriatric Trauma Patients. Journal of orthopaedic trauma, 32(9), 461-466.
Read More
Osteonecrosis After Surgically Repaired Proximal Humerus Fractures Is a Predictor of Poor Outcomes
Belayneh, R., Lott, A., Haglin, J., Konda, S., Zuckerman, J. D., & Egol, K. A. (2018). Osteonecrosis After Surgically Repaired Proximal Humerus Fractures Is a Predictor of Poor Outcomes. Journal of orthopaedic trauma, 32(10), e387-e393.
Read More
Incidence and impact of new-onset atrial fibrillation on transcatheter mitral valve repair
Doshi, R., Patel, K., Desai, R., Patel, K., & Gupta, R. (2018). Incidence and impact of new-onset atrial fibrillation on transcatheter mitral valve repair. European journal of internal medicine.
Read More
